SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gaudium IVF & Women Health lists at 5% premium on the BSE

27 Feb 2026 Evaluate

Gaudium IVF & Women Health has debuted at Rs 83.00 on the BSE, up by 4 points or 5.06% from its issue price of Rs 79.00.

The scrip is currently trading at Rs. 80.75, up by 1.75 points or 2.22% from its issue price.

It has touched a high and low of Rs. 87.15 and Rs. 79.05 respectively. So far 4.19 lakh shares were traded on the counter.

The offering, which was open for subscription between February 20, 2026 and February 24, 2026 was subscribed 7.27 times. The issue price was fixed at Rs 79.00 per share i.e. at upper end of price band of Rs 75-79 apiece.

Gaudium IVF & Women Health is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.

Gaudium IVF & Women Share Price

105.35 -2.15 (-2.00%)
05-Jun-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×